Analysts think DSM is fairly priced

DSM's stock price seems, partly because of the recent share price rises, to be in line with most of the estimates. Most of the analysts say DSM is fairly priced now. Currently the company is being followed by 16 analysts. The average target price for the stock is at 114,75 euros. This is around 0,09 percent less than the current stock price of 115,3 euros.

Fair values for DSM vary a lot

equity research

For this year DSM's revenue will be around 9,13 billion euros. This is according to the average of the analysts' estimates. This is slightly lower than 2018's revenue of 9,27 billion euros.

Historical revenues and results DSM plus estimates 2019

fundamental research

The analysts expect for 2019 a net profit of 847 million euros. For this year the consensus of DSM's result per share is a profit of 4,9 euros. So the price/earnings-ratio equals 23,53.

Analysts expect a dividend of 2,43 euros per share. Thus the dividend yield equals 2,11 percent. The average dividend yield of the chemical companies equals an attractive 81 percent.

Recent target prices around 108 euros

ING, Baader Bank and Sanford C. Bernstein & Co recently provided recommendations for the stock.

DSM's market value equals around 20,18 billion . The DSM stock was the past 12 months quite volatile. Since last December the stock is even 66 percent higher. This year the stock price moved between 68 and 118 euro.

Historical stock prices DSM

fundamental research dsm

Click here for dividend . At 12.47 the stock trades 1,08 percent higher at 115,3 euros. Nieuwsdienst: +31 084-0032-842

Copyright B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.